Does autogenous S. suis vaccination of gilts protect their piglets?
A multiserotype autogenous vaccine in gilts improved maternal antibody transfer to about five weeks of age but did not reduce shedding or demonstrate clinical protection.
Concise summaries of published swine health and production research, organized for quick discovery.
A multiserotype autogenous vaccine in gilts improved maternal antibody transfer to about five weeks of age but did not reduce shedding or demonstrate clinical protection.
In a mouse model of S. suis, T-cell-dependent IgM played a major role in bacterial clearance, a mechanism that still requires translation to pigs.
Genomic and phenotypic analysis of S. suis serotype 4 found potentially pathogenic lineages and extensive multidrug resistance, without implying equal risk from every isolate.
Among apparently healthy slaughter pigs in Thailand, S. suis was common and genetically diverse, but molecular markers did not perfectly distinguish commensal from pathogenic strains.
A peer-learning and e-learning intervention was associated with substantial reductions in antimicrobial use on farms with S. suis problems.